Article
The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein…
Journal of Asthma and Allergy · 2025 · Rimkunas A, Januskevicius A, Vasyle E, Palacionyte J, Kalinauskaite-Zukauske V, Miliauskas S, Malakauskas K
Key facts
| Title | The Effect of Mepolizumab on Blood Eosinophil Subtype Distribution and Granule Protein Gene Expression in Severe Eosinophilic Asthma |
|---|---|
| First author | Rimkunas A, Januskevicius A, Vasyle E, Palacionyte J, Kalinauskaite-Zukauske V, Miliauskas S, Malakauskas K |
| Journal | Journal of Asthma and Allergy |
| Published | Mar 29, 2025 |
| DOI | 10.2147/JAA.S509001 |
| Devices mentioned | 202301, BK120015, BK120068, BK200525, K010696, K023239, K023764, K042291, K060256, K081930, K091332, K103842 and 21 more |
| Product codes mentioned | CDD, CDP, CDZ, CEC, CEP, CFL, CFP, CFT, CGJ, CGN, CHP, CKG and 36 more |
At a glance
- 10–99 FDA submissions mentioned
- 10–99 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1